CompletedPhase 2NCT04026958

Clarithromycin Mechanisms in Hypersomnia Syndromes

Studying Idiopathic hypersomnia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Lynn Marie Trotti, MD, MSc
Emory University
Intervention
Clarithromycin(drug)
Enrollment
83 enrolled
Eligibility
18-60 years · All sexes
Timeline
2019 – 2025

Study locations (1)

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04026958 on ClinicalTrials.gov

Other trials for Idiopathic hypersomnia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic hypersomnia →

← Back to all trials